Another important outcome from the previous characterization study was a significant increase in the infiltration of immune cells in the TMPRSS2-ERG fusion-positive tumors, including a stage-specific increase, compared to fusion-negative tumors in preclinical PCa mouse models [12]. The gene discussed is ERG; the disease is posterior cortical atrophy.